BG51918A1 - Composition to prevent seasickness (nausea) - Google Patents

Composition to prevent seasickness (nausea)

Info

Publication number
BG51918A1
BG51918A1 BG85278A BG8527888A BG51918A1 BG 51918 A1 BG51918 A1 BG 51918A1 BG 85278 A BG85278 A BG 85278A BG 8527888 A BG8527888 A BG 8527888A BG 51918 A1 BG51918 A1 BG 51918A1
Authority
BG
Bulgaria
Prior art keywords
mammals
nausea
composition
people
undesired
Prior art date
Application number
BG85278A
Other languages
English (en)
Inventor
Gyoergy Bodo
Jozsef Knoll
Eva Somfai
Sandor Virag
Ferenc Zak
Original Assignee
Hu Chinoin Gyogyszer Es Vegyes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hu Chinoin Gyogyszer Es Vegyes filed Critical Hu Chinoin Gyogyszer Es Vegyes
Publication of BG51918A1 publication Critical patent/BG51918A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
BG85278A 1986-12-19 1988-08-18 Composition to prevent seasickness (nausea) BG51918A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU865338A HU197510B (en) 1986-12-19 1986-12-19 Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick

Publications (1)

Publication Number Publication Date
BG51918A1 true BG51918A1 (en) 1993-11-15

Family

ID=10970131

Family Applications (1)

Application Number Title Priority Date Filing Date
BG85278A BG51918A1 (en) 1986-12-19 1988-08-18 Composition to prevent seasickness (nausea)

Country Status (26)

Country Link
US (1) US4925878A (xx)
EP (1) EP0294441B1 (xx)
JP (1) JP2534553B2 (xx)
AT (1) ATE82847T1 (xx)
BG (1) BG51918A1 (xx)
CY (1) CY1740A (xx)
CZ (1) CZ277831B6 (xx)
DD (1) DD264851A5 (xx)
DE (1) DE3782935T2 (xx)
DK (1) DK464788A (xx)
ES (1) ES2009228A6 (xx)
FI (1) FI883837A0 (xx)
GE (1) GEP19970949B (xx)
GR (1) GR871953B (xx)
HK (1) HK105193A (xx)
HU (1) HU197510B (xx)
IL (1) IL84786A (xx)
LT (1) LT4007B (xx)
LV (1) LV10185B (xx)
MD (1) MD408C2 (xx)
MX (1) MX9203088A (xx)
PT (1) PT86406B (xx)
RU (1) RU1825314C (xx)
SK (1) SK278500B6 (xx)
UA (1) UA19281A1 (xx)
WO (1) WO1988004552A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
CS269271B1 (en) * 1988-05-30 1990-04-11 Hajicek Josef Method of selegiline's hydrochloride production
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
EP0578687A1 (en) * 1991-04-04 1994-01-19 The University Of Toronto Innovations Foundation Use of deprenyl to maintain, prevent loss, or recover nerve cell function
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
ES2149850T3 (es) * 1993-05-04 2000-11-16 Ceva Sante Animale Utilizacion de la selegilina en medicina veterinaria.
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
DE69520430T2 (de) 1994-06-03 2001-10-18 Jmde Trust Newton Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
US6033682A (en) * 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
WO1996024346A1 (en) * 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
DE69628415T3 (de) * 1995-03-02 2008-06-26 R.P. Scherer Technologies, Inc., Paradise Valley Arzneimittel enthaltend monoaminooxidase-b-hemmer
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
US6042533A (en) * 1998-07-24 2000-03-28 Kania; Bruce Apparatus and method for relieving motion sickness
US6197329B1 (en) 1999-05-03 2001-03-06 Drugtech Corporation Anti-nausea compositions and methods
US6443913B1 (en) 2000-03-07 2002-09-03 Bruce Kania Apparatus and method for relieving motion sickness
US6497649B2 (en) * 2001-01-21 2002-12-24 University Of Washington Alleviating motion, simulator, and virtual environmental sickness by presenting visual scene components matched to inner ear vestibular sensations
US7128705B2 (en) * 2002-11-26 2006-10-31 Artis Llc Motion-coupled visual environment for prevention or reduction of motion sickness and simulator/virtual environment sickness
AT16235U1 (de) * 2018-06-21 2019-04-15 Dr Reinhart Jarisch Kaugummi enthaltend Vitamin C

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
GB1031425A (en) * 1962-03-30 1966-06-02 Chinoin Gyogyszer Es Vegyeszet New aralkylamines and their preparation
EP0564802B1 (de) 1992-04-10 1996-10-09 Schott Glaswerke Blei- und bariumfreies Kristallglas mit hoher Lichttransmission

Also Published As

Publication number Publication date
ATE82847T1 (de) 1992-12-15
LV10185B (en) 1995-04-20
MX9203088A (es) 1992-07-01
SK278500B6 (en) 1997-05-14
CZ277831B6 (en) 1993-06-16
JPH01501626A (ja) 1989-06-08
CY1740A (en) 1995-10-20
EP0294441A1 (en) 1988-12-14
LT4007B (en) 1996-07-25
PT86406B (pt) 1990-11-20
FI883837A (fi) 1988-08-18
UA19281A1 (uk) 1997-12-25
DD264851A5 (de) 1989-02-15
HUT45196A (en) 1988-06-28
DK464788D0 (da) 1988-08-18
CS8709491A1 (en) 1990-05-14
HU197510B (en) 1989-04-28
LV10185A (lv) 1994-10-20
US4925878A (en) 1990-05-15
JP2534553B2 (ja) 1996-09-18
MD408C2 (ro) 1996-07-31
IL84786A (en) 1991-08-16
GR871953B (en) 1988-04-19
RU1825314C (ru) 1993-06-30
EP0294441B1 (en) 1992-12-02
LTIP1849A (en) 1995-08-25
PT86406A (en) 1988-01-01
DE3782935D1 (de) 1993-01-14
GEP19970949B (en) 1997-03-31
DE3782935T2 (de) 1993-04-08
DK464788A (da) 1988-08-18
FI883837A0 (fi) 1988-08-18
HK105193A (en) 1993-10-15
ES2009228A6 (es) 1989-09-16
WO1988004552A1 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
BG51918A1 (en) Composition to prevent seasickness (nausea)
DK179286D0 (da) Insulinpraeparat
IE873125L (en) Benzimidazole derivatives
NO824062L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
DK155186A (da) Aminopropanolderivater, fremgangsmaade til fremstilling deraf samtlaegemidler, der indeholder dem
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
ZA818499B (en) Agents for combating circulatory illnesses and their use
EP0261595A3 (en) Pharmaceutical composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-didehydrocytidine) for treating patients infected with retrovirus
MY104942A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
ES327089A1 (es) Un metodo para preparar alfa-ditiosemicarbazonas.
GR852395B (xx)
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
PH23818A (en) Enhancement of activity of alpha-adrenoceptor antagonists
MC1930A1 (fr) Produit antiviral
JPS6438030A (en) Preventing and treating agent for aids
MY106961A (en) Antiviral tetrahydroimidazo[1,4] benzodiazepines
EP0178176A3 (en) Tetrahydro-1,2,4-oxadiazine-5-thione derivatives
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
SU1744810A1 (ru) Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон"
SU1139143A1 (ru) Гидрохлорид 3-(2-диэтиламиноэтилтио)-9-метил-1,2,4-триазино/6,5-в/ индола, обладающий противогипоксической активностью
FR2224152A1 (en) Thiazolotriazolyl phosphorothioates as anthelmintics - combining good anthelmintic activity with low toxicity to warm-blooded animals
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it